Last reviewed · How we verify
NCT06610214: IMPACT-care
IMPACT-care (Improved Medication Communication and Patient Involvement at Care Transitions)
NA trial testing IMPACT-care intervention in Continuity of Patient Care in 231 participants. Completed in 14 January 2026.
14 January 2026
Quick facts
| Lead sponsor | Uppsala University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 231 |
| Start date | 16 September 2024 |
| Primary completion | 14 January 2026 |
| Estimated completion | 14 January 2026 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- IMPACT-care intervention
Conditions studied
- Continuity of Patient Care — all drugs for Continuity of Patient Care →
Sponsor
Uppsala University Hospital
Who can join
65 and older, any sex, with Continuity of Patient Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Transitions of care, especially at hospital discharge, pose significant risks to patient safety. The World Health Organization (WHO) identifies this as a critical area for improvement, particularly for older patients who frequently experience preventable adverse drug events (ADEs) post-discharge.These risks often stem from poor communication between hospitals and subsequent care providers, and inadequate communication with patients and their informal caregivers, leading to gaps in post-discharge care. In Sweden, discharge conversations between hospital physicians and patients are standard practice but often lack structure and patient-centeredness. This can result in patients being poorly prepared for self-care, especially in managing their medications. Aim: To improve the discharge process for older patients, making them (and/or informal caregiver) more informed and involved in their overall care, particularly in medication management. Design: Prospective intervention study with a before-and-after design, supplemented by an Interrupted Time Series (ITS) analysis using an exploratory approach. Setting: Two surgical and one geriatric ward in Region Uppsala. Participants: Patients aged 65 or older, managing medication independently or with assistance from an informal caregiver. Exclusion: Late palliative stage or transition to it during hospital stay; transfer to a non-participating ward; residence outside the hospital's county; admission from or discharge to a nursing home or short-term care facility; inability to receive information and give consent independently (e.g., cognitive impairment, non-contactable); death during hospital stay; inability to communicate in Swedish; previous inclusion in the study; relocation where another department maintains care responsibility; no persistent medication change post-discharge; hospital stay on the study ward of less than 48 weekday hours. Interventions: 1, Information package for patient and/or informal caregiver 2, Preparation of medication-related discharge documentation; 3, Facilitation of discharge communication; 4, Post-discharge follow-up call Primary outcome measure: Quality of medication-related discharge documentation. Data collection and analyses: Data will be collected from patients' electronic health records (EHR), the Swedish National Board of Health and Welfare's Pharmaceutical Register, and research surveys. Analyses will follow the intention-to-treat principle, using descriptive statistics, t-tests for continuous variables, and chi-square tests for categorical variables. Relevance: The study aims to enhance the quality of discharge documentation, improve patients adherence to medication changes, increase their sense of participation and involvement in their overall care, and reduce healthcare consumption.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improved Medication communication and Patient involvement At Care Transitions (IMPACT-care): study protocol for a pre-post intervention trial in older hospitalised patients.
Cam H, Franzon K, Östman V, Kälvemark Sporrong S, et al · · 2025 · PMID 40316362 · DOI 10.1136/bmjopen-2025-099547
Verify or expand the search:
- PubMed search for NCT06610214
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Continuity of Patient Care
Currently open trials in the same condition.
- NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study · NA · recruiting
- NCT06753266 — Optimizing OR Simulation in MEDI 045: Bias Reduction and Strategic Improvements (OPTIMIST) · active not recruiting
- NCT03616990 — Supportive Release Center Study · NA · active not recruiting
Other Uppsala University Hospital trials
Trials by the same sponsor.
- NCT06848660 — Study on Orthosis in Cervical Spine Fracture Treatment · NA · recruiting
- NCT06621381 — Concentrated Exposure and Response Prevention for Children With Obsessive-compulsive Disorder · NA · recruiting
- NCT06372444 — Mechanisms of Acute Kidney Injury in Severe Infections · recruiting
- NCT06261411 — Lung Ultrasound as Alternative to Radiography in Thoracic Surgery · NA · active not recruiting
- NCT05814887 — Reduction of Mechanical IV Complication Using a New Medical Device · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06610214 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uppsala University Hospital
- Last refreshed: 5 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06610214.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing